Shape-memory polymer

TMD LAB Collaborates With US NIST to Reveal the Secrets of Shape-memory Polymer Materials

Retrieved on: 
Monday, November 14, 2022
Health, Medical Devices, Surgery, Health Technology, Research, Science, Biotechnology, Shape-memory polymer, Cooperative research and development agreement, LAB, Silicon, U.S. Department of Commerce Office of Security, NIST, National Institute of Standards and Technology, DNA, Commerce, SMP, Research, Thermoregulation, TMD, Development, Biofilm, U.S. Department of Defense Strategy for Operating in Cyberspace, Medical device, CRADA

TMD LAB received a Cooperative Research and Development Agreement (CRADA) proposal from the NIST and signed the agreement on October 11 2022.

Key Points: 
  • TMD LAB received a Cooperative Research and Development Agreement (CRADA) proposal from the NIST and signed the agreement on October 11 2022.
  • TMD LAB and the biomaterials group of NIST signed a confidential disclosure agreement for joint research in April last year.
  • In addition, basic research on the structural properties of SMP of TMD LAB has been conducted.
  • TMD LAB Co., Ltd., established in 2018, is a company that is developing implantable medical devices using Shape Memory Polymer (SMP), high-tech new materials.

Global Market for Shape Memory Materials 2023-2033 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 31, 2022
Other Manufacturing, Manufacturing, Polymer, SMA, AG, Mix, SMP, Robotics, Spinal muscular atrophies, Pressure, Shape-memory polymer, Radiation, PH, Microvalve, Material, Microwave, SMPS, Dental Materials, Deformation (engineering), CML, Textile, Unmanned aerial vehicle, Positive economics, Shape-memory alloy, Electronics, Aluminium alloy, 3D printing, Ceramic, Titanium, Joule

The "The Global Market for Shape Memory Materials 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The Global Market for Shape Memory Materials 2023-2033" report has been added to ResearchAndMarkets.com's offering.
  • Shape memory materials are a widely-investigated class of smart materials capable of changing from one predetermined shape to another in response to a stimulus.
  • The demand for structures capable of autonomously adapting their shape according to specific varying conditions has led to the development of shape memory materials such as Shape Memory Alloys (SMA) and Shape Memory Polymers (SMP).
  • The Global Market for Shape Memory Materials 2023-2033 includes:
    Applications and markets for shape memory alloys and shape memory polymers.

Shape Memory Medical Announces First Patient Enrollment in the AAA-SHAPE Netherlands Study

Retrieved on: 
Tuesday, August 24, 2021
Research, Surgery, Medical Devices, Hospitals, Clinical Trials, Cardiology, Health, General Health, Science, Blood, PMDA, Bachelor of Medicine, Bachelor of Surgery, Trial of the century, Memory, Auckland City Hospital, CE, Holden, Doctor of Philosophy, Abdominal aortic aneurysm, Neurovascular bundle, Learning, Shape-memory polymer, EVAR, Patient, AAA, MD, Medical imaging

The Dutch studys first procedure was performed by Professor Michel Reijnen, MD, PhD, vascular surgeon at Rijnstate Hospital in Arnhem, the Netherlands.

Key Points: 
  • The Dutch studys first procedure was performed by Professor Michel Reijnen, MD, PhD, vascular surgeon at Rijnstate Hospital in Arnhem, the Netherlands.
  • Ted Ruppel, President and Chief Executive Officer of Shape Memory Medical Inc. said, "We would like to congratulate Professor Reijnen and the clinical study team at Rijnstate Hospital for a successful first AAA-SHAPE case in the Netherlands.
  • The study will enroll up to 15 patients across three centers in the Netherlands, contributing to the AAA-SHAPE safety study which is also currently enrolling up to 15 patients in Auckland, New Zealand.
  • Shape Memory Medical Inc. is dedicated to developing innovative therapeutic solutions with its proprietary shape memory polymers.

Shape Memory Medical Receives PMDA Approval for the IMPEDE-FX Embolization Plug

Retrieved on: 
Tuesday, March 23, 2021
Cardiology, Biotechnology, Pharmaceutical, Surgery, General Health, Health, Medical devices, Other Health, Interventional radiology, PMDA, Embolization, Shape-memory polymer, Applied sciences

Shape Memory Medical Inc. announced today that it has received approval from Japans Pharmaceuticals and Medical Devices Agency (PMDA) to market its IMPEDE-FX Embolization Plug in Japan.

Key Points: 
  • Shape Memory Medical Inc. announced today that it has received approval from Japans Pharmaceuticals and Medical Devices Agency (PMDA) to market its IMPEDE-FX Embolization Plug in Japan.
  • We are excited about the opportunity this approval brings to the Japanese market to expand, said Ted Ruppel, President and CEO of Shape Memory Medical.
  • The IMPEDE-FX Embolization Plug is indicated for use in Japan as an adjunct to devices such as stents, coils, and plugs, and the IMPEDE Embolization Plug which previously received PMDA approval in 2019.
  • Shape Memory Medical Inc. is dedicated to developing innovative therapeutic solutions with its proprietary Shape Memory Polymers.

Shape Memory Medical Receives CE Mark for IMPEDE-FX RapidFill

Retrieved on: 
Wednesday, March 10, 2021
Science, Cardiology, Other Science, Biotechnology, Health, FDA, Medical devices, Clinical trials, Smart materials, Interventional radiology, Chemistry, Embolization, Surgery, Physical sciences, Shape-memory polymer, Shape-memory alloy, Applied sciences

Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced CE Mark Approval for the IMPEDE-FX RapidFill Device, an expansion of the IMPEDE family of biodegradable peripheral vascular embolization plugs.

Key Points: 
  • Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced CE Mark Approval for the IMPEDE-FX RapidFill Device, an expansion of the IMPEDE family of biodegradable peripheral vascular embolization plugs.
  • Ted Ruppel, President and CEO of Shape Memory Medical Inc. said, "We are excited to introduce IMPEDE-FX RapidFill to the endovascular community in Europe.
  • The IMPEDE family includes the IMPEDE Embolization Plug, the IMPEDE-FX Embolization Plug, and now IMPEDE-FX RapidFill which consists of five IMPEDE-FX-12 embolization plugs preloaded into a single delivery introducer.
  • Shape Memory Medical Inc. is dedicated to developing innovative therapeutic solutions with its proprietary Shape Memory Polymers.

New Chemistries in Smart Polymers Market to Increasingly Capitalize on Avenues in Biomedical Sector, Market to Clock CAGR of 14% from 2020 to 2030: TMR

Retrieved on: 
Wednesday, December 9, 2020
Smart materials, Polymers, Polymer chemistry, Applied sciences, Matter, Branches of science, Smart polymer, Shape-memory polymer

The rise in utilization of smart polymers in making advanced packaging materials is spurring new opportunities in the smart polymers market.

Key Points: 
  • The rise in utilization of smart polymers in making advanced packaging materials is spurring new opportunities in the smart polymers market.
  • Companies are leveraging the strength of new chemistries in the smart polymers market by garnering gains from the application of shape memory polymers.
  • Strides made in the chemistries of smart polymers market are continuously unlocking new prospects in the smart polymers market.
  • Growing adoption of smart polymers in biotechnology and automotive sector is spurring the growth prospects in the Asia Pacific smart polymers market.

Shape Memory Medical Names Mary Dennehy as Vice President of Marketing

Retrieved on: 
Friday, September 25, 2020
Biotechnology, Health, Cardiology, Medical devices, Physical sciences, Chemistry, Natural sciences, Smart materials, Polymer chemistry, Polymers, Shape-memory polymer, Nickel titanium

Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, is pleased to announce and welcome Mary Dennehy as Vice President of Marketing.

Key Points: 
  • Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, is pleased to announce and welcome Mary Dennehy as Vice President of Marketing.
  • Mary will be responsible for driving the development and implementation of global marketing strategies and initiatives that support commercialization of its Shape Memory Polymer embolization products and therapies.
  • I am very excited to join the Shape Memory Medical team and to be a part of an organization with such an innovative and unique portfolio, said Mary of her new position.
  • Shape Memory Medical Inc., based in Santa Clara, California, is dedicated to developing innovative therapeutic solutions with its proprietary Shape Memory Polymers.

Shape Memory Medical Announces First Patient Enrollment in AAA-SHAPE Study

Retrieved on: 
Wednesday, September 16, 2020
Health, Surgery, Cardiology, Medical devices, Smart materials, Physical sciences, Chemistry, Natural sciences, Polymers, Polymer chemistry, Embolization, Interventional radiology, Surgery, Shape-memory polymer, Shape-memory alloy

Ted Ruppel, Chief Executive Officer of Shape Memory Medical Inc., said, "We would like to congratulate Dr. Holden, Mr. Hill and the clinical study team at Auckland City Hospital for completing the first procedure in the AAA-SHAPE study.

Key Points: 
  • Ted Ruppel, Chief Executive Officer of Shape Memory Medical Inc., said, "We would like to congratulate Dr. Holden, Mr. Hill and the clinical study team at Auckland City Hospital for completing the first procedure in the AAA-SHAPE study.
  • The IMPEDE-FX Embolization Plug is comprised of Shape Memory Polymer which is a porous, embolic scaffold.
  • We are excited to be part of the AAA-SHAPE study," said Dr. Andrew Holden, principal investigator for the study.
  • Shape Memory Medical Inc., based in Santa Clara, California, is dedicated to developing innovative therapeutic solutions with its proprietary Shape Memory Polymers.

Shape Memory Medical Receives PMDA Approval for the IMPEDE® Embolization Plug Family

Retrieved on: 
Monday, December 2, 2019
Health, Surgery, Cardiology, Medical devices, Interventional radiology, PMDA, Embolization, Shape-memory polymer, Applied sciences, COSMOTEC, Shape Memory Medical

Shape Memory Medical Inc. announced today that its IMPEDE Embolization Plugs have been approved in Japan by the Pharmaceuticals and Medical Devices Agency (PMDA).

Key Points: 
  • Shape Memory Medical Inc. announced today that its IMPEDE Embolization Plugs have been approved in Japan by the Pharmaceuticals and Medical Devices Agency (PMDA).
  • IMPEDE Embolization Plugs feature proprietary shape memory polymer (SMP) technology.
  • Commenting on this regulatory approval, Shape Memory Medicals President and CEO, Ted Ruppel, said, We are excited to receive PMDA Approval for our IMPEDE Embolization Plugs.
  • We are looking forward to providing this new type of embolization devices in partnership with Shape Memory Medical.

Shape Memory Medical Wins 2019 R&D 100 Award for Its Novel Impede® Embolization Device

Retrieved on: 
Monday, November 4, 2019
Medical devices, Health, Smart materials, Chemistry, Physical sciences, Applied sciences, Shape-memory polymer, Shape-memory alloy, Embolization, SMP, Polymer

Shape Memory Medical is delighted to announce that the IMPEDE Embolization Plug, a member of its innovative line of vascular embolization products, has won one of the 2019 R&D 100 Awards ( https://www.rd100conference.com/ ).

Key Points: 
  • Shape Memory Medical is delighted to announce that the IMPEDE Embolization Plug, a member of its innovative line of vascular embolization products, has won one of the 2019 R&D 100 Awards ( https://www.rd100conference.com/ ).
  • The IMPEDE family of peripheral vascular embolization products all include shape memory polymer (SMP), the core technology of Shape Memory Medicals expanding product lines.
  • Shape Memory Medical was founded to develop and commercialize solutions for a variety of clinical applications using this novel technology.
  • Shape Memory Medical Inc., based in Santa Clara, California, is committed to developing multiple medical therapies with their novel shape memory polymers.